Bachem Holding AG (OTCMKTS:BCHMF – Get Free Report)’s share price dropped 4.3% during mid-day trading on Thursday . The company traded as low as $87.34 and last traded at $87.34. Approximately 359 shares were traded during trading, a decline of 45% from the average daily volume of 656 shares. The stock had previously closed at $91.23.
Bachem Price Performance
The stock has a 50-day moving average of $88.49 and a two-hundred day moving average of $77.02.
Bachem Company Profile
Bachem Holding AG is a Switzerland‐based specialty biochemical company focused on the development, manufacturing and commercialization of peptides and oligonucleotides. Serving pharmaceutical and biotechnology clients as well as academic research institutions, the company offers a broad spectrum of products ranging from custom peptide synthesis for research applications to clinical and commercial‐grade active pharmaceutical ingredients (APIs). Bachem’s expertise extends to process development, scale‐up and GMP‐compliant production, supporting projects in therapeutic areas such as oncology, metabolic disorders and infectious diseases.
Founded in 1971 and headquartered in Bubendorf, Switzerland, Bachem has grown through strategic investments in production capacity and the acquisition of complementary peptide and oligonucleotide technologies.
See Also
- Five stocks we like better than Bachem
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Bachem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bachem and related companies with MarketBeat.com's FREE daily email newsletter.
